Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-08-22 00:00:00 ET · period of report 2024-08-21 · accession 0000950170-24-099982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-08-22 | 2024-08-21 | VKTX | Lian Brian | Pres, CEO, Dir | S - Sale+OE | $69.90 | -1,000 | 2.35M | -0.0% | -$69.9K |
| DT | 2024-08-22 | 2024-08-21 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $7.77 | +1,000 | 2.36M | +0.0% | +$7,770 |
| DT | 2024-08-22 | 2024-08-21 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $0.00 | -1,000 | 231.1K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-08-21 | S | D | 1,000 | $69.90 | 2,354,927 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-08-21 | M | A | 1,000 | $7.77 | 2,355,927 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-21 | M | D | 1,000 | $0.00 | 231,130 | D | $7.77 · 2021-01-03 to 2030-01-03 | 1,000 Common Stock | (F2) 25% of the shares subject to the option vested on each anniversary of the grant date. |